Skip to main content
Nicholas Nickols, MD, Radiation Oncology, Los Angeles, CA

Nicholas George Nickols MD


Physician

Join to view full profile
  • 200 Medical Plaza, Suite B265Los Angeles, CA 90095

  • Phone+1 310-825-9775

  • Fax+1 310-825-9775

Dr. Nickols is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2010 - 2014
  • University of California (Irvine)
    University of California (Irvine)Internship, Internal Medicine, 2009 - 2010
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2009

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2028
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Incorporating PSMA PET into Radiotherapy Planning: Impact on Definitive Therapy "Presentation" - Nicholas NickolsFebruary 2024

Press Mentions

  • Shorter Radiation Treatment After Surgery Found Safe for Prostate Cancer Patients
    Shorter Radiation Treatment After Surgery Found Safe for Prostate Cancer PatientsMay 14th, 2025
  • Three UCLA/VA Researchers to Be Honored by Secretary of Veterans Affairs
    Three UCLA/VA Researchers to Be Honored by Secretary of Veterans AffairsMay 4th, 2023
  • ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate Cancer
    ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021

Grant Support

  • Phase II Trial of targeted Radiation with no castration for mcrpc (POTENT-C)VA GREATER LOS ANGELES HEALTHCARE SYSTEM2024–2028
  • Predicting Metastatic Progression of High Risk Localized Prostate CancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2023–2027

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: